ZBH
Income statement / Annual
Last year (2024), Zimmer Biomet Holdings, Inc.'s total revenue was $7.68 B,
an increase of 3.85% from the previous year.
In 2024, Zimmer Biomet Holdings, Inc.'s net income was $903.80 M.
See Zimmer Biomet Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$7.68 B |
$7.39 B |
$6.94 B |
$6.83 B |
$6.13 B |
$7.98 B |
$7.93 B |
$7.80 B |
$7.67 B |
$6.00 B |
| Cost of Revenue |
$2.19 B
|
$2.08 B
|
$2.02 B
|
$1.96 B
|
$1.82 B
|
$2.25 B
|
$2.27 B
|
$2.13 B
|
$2.38 B
|
$1.80 B
|
| Gross Profit |
$5.49 B
|
$5.31 B
|
$4.92 B
|
$4.87 B
|
$4.30 B
|
$5.73 B
|
$5.66 B
|
$5.67 B
|
$5.29 B
|
$4.20 B
|
| Gross Profit Ratio |
0.71
|
0.72
|
0.71
|
0.71
|
0.7
|
0.72
|
0.71
|
0.73
|
0.69
|
0.7
|
| Research and Development Expenses |
$437.40 M
|
$458.70 M
|
$406.00 M
|
$435.80 M
|
$322.80 M
|
$449.30 M
|
$391.70 M
|
$369.90 M
|
$365.60 M
|
$268.80 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.38 B
|
$3.37 B
|
$2.94 B
|
$2.66 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$265.00 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.93 B
|
$2.84 B
|
$2.76 B
|
$2.84 B
|
$2.71 B
|
$3.34 B
|
$3.38 B
|
$3.10 B
|
$2.94 B
|
$2.66 B
|
| Other Expenses |
$834.50 M
|
$735.10 M
|
$1.06 B
|
$727.40 M
|
$1.18 B
|
$799.00 M
|
$1.86 B
|
$1.40 B
|
$1.16 B
|
$800.60 M
|
| Operating Expenses |
$4.20 B
|
$4.03 B
|
$4.22 B
|
$4.01 B
|
$4.22 B
|
$4.59 B
|
$5.63 B
|
$4.87 B
|
$4.47 B
|
$3.73 B
|
| Cost And Expenses |
$6.39 B
|
$6.12 B
|
$6.24 B
|
$5.97 B
|
$6.04 B
|
$6.84 B
|
$7.90 B
|
$7.00 B
|
$6.85 B
|
$5.53 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$9.40 M
|
| Interest Expense |
$218.00 M
|
$201.20 M
|
$164.80 M
|
$208.40 M
|
$212.10 M
|
$226.90 M
|
$289.30 M
|
$325.30 M
|
$355.00 M
|
$286.60 M
|
| Depreciation & Amortization |
$996.30 M
|
$951.70 M
|
$926.40 M
|
$937.70 M
|
$898.40 M
|
$1.01 B
|
$1.04 B
|
$1.06 B
|
$1.04 B
|
$712.40 M
|
| EBITDA |
$2.25 B |
$2.22 B |
$1.49 B |
$1.65 B |
$1.01 B |
$2.14 B |
$1.06 B |
$1.85 B |
$1.79 B |
$1.15 B |
| EBITDA Ratio |
0.29
|
0.3
|
0.22
|
0.24
|
0.16
|
0.27
|
0.13
|
0.24
|
0.23
|
0.19
|
| Operating Income Ratio |
0.17
|
0.17
|
0.1
|
0.13
|
0.01
|
0.14
|
0
|
0.1
|
0.11
|
0.08
|
| Total Other Income/Expenses Net |
-$249.10 M
|
-$210.40 M
|
-$292.80 M
|
-$361.30 M
|
-$188.30 M
|
-$231.70 M
|
-$304.90 M
|
-$334.70 M
|
-$421.50 M
|
-$314.10 M
|
| Income Before Tax |
$1.04 B
|
$1.07 B
|
$403.50 M
|
$499.00 M
|
-$105.20 M
|
$905.80 M
|
-$271.10 M
|
$464.60 M
|
$399.60 M
|
$153.20 M
|
| Income Before Tax Ratio |
0.13
|
0.14
|
0.06
|
0.07
|
-0.02
|
0.11
|
-0.03
|
0.06
|
0.05
|
0.03
|
| Income Tax Expense |
$131.40 M
|
$42.20 M
|
$112.30 M
|
$53.50 M
|
-$96.00 M
|
-$225.70 M
|
$108.20 M
|
-$1.35 B
|
$95.00 M
|
$7.00 M
|
| Net Income |
$903.80 M
|
$1.02 B
|
$231.40 M
|
$401.60 M
|
-$138.90 M
|
$1.13 B
|
-$379.20 M
|
$1.81 B
|
$305.90 M
|
$147.00 M
|
| Net Income Ratio |
0.12
|
0.14
|
0.03
|
0.06
|
-0.02
|
0.14
|
-0.05
|
0.23
|
0.04
|
0.02
|
| EPS |
4.45 |
4.91 |
1.1 |
1.93 |
-0.67 |
5.52 |
-1.86 |
9.11 |
1.51 |
0.27 |
| EPS Diluted |
4.43 |
4.88 |
1.1 |
1.91 |
-0.67 |
5.47 |
-1.86 |
9.03 |
1.5 |
0.26 |
| Weighted Average Shares Out |
$203.10 M
|
$208.70 M
|
$209.60 M
|
$208.60 M
|
$207.00 M
|
$205.10 M
|
$203.50 M
|
$201.90 M
|
$200.00 M
|
$187.40 M
|
| Weighted Average Shares Out Diluted |
$203.90 M
|
$209.70 M
|
$210.30 M
|
$210.40 M
|
$207.00 M
|
$206.70 M
|
$203.50 M
|
$203.70 M
|
$202.40 M
|
$189.80 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
